Current:Home > InvestExperimental gene therapy allows kids with inherited deafness to hear-VaTradeCoin
Experimental gene therapy allows kids with inherited deafness to hear
lotradecoin services View Date:2024-12-25 22:40:36
Gene therapy has allowed several children born with inherited deafness to hear.
A small study published Wednesday documents significantly restored hearing in five of six kids treated in China. On Tuesday, the Children’s Hospital of Philadelphia announced similar improvements in an 11-year-old boy treated there. And earlier this month, Chinese researchers published a study showing much the same in two other children.
So far, the experimental therapies target only one rare condition. But scientists say similar treatments could someday help many more kids with other types of deafness caused by genes. Globally, 34 million children have deafness or hearing loss, and genes are responsible for up to 60% of cases. Hereditary deafness is the latest condition scientists are targeting with gene therapy, which is already approved to treat illnesses such as sickle cell disease and severe hemophilia.
Children with hereditary deafness often get a device called a cochlear implant that helps them hear sound.
“No treatment could reverse hearing loss … That’s why we were always trying to develop a therapy,” said Zheng-Yi Chen of Boston’s Mass Eye and Ear, a senior author of the study published Wednesday in the journal Lancet. “We couldn’t be more happy or excited about the results.”
The team captured patients’ progress in videos. One shows a baby, who previously couldn’t hear at all, looking back in response to a doctor’s words six weeks after treatment. Another shows a little girl 13 weeks after treatment repeating father, mother, grandmother, sister and “I love you.”
All the children in the experiments have a condition that accounts for 2% to 8% of inherited deafness. It’s caused by mutations in a gene responsible for an inner ear protein called otoferlin, which helps hair cells transmit sound to the brain. The one-time therapy delivers a functional copy of that gene to the inner ear during a surgical procedure. Most of the kids were treated in one ear, although one child in the two-person study was treated in both ears.
The study with six children took place at Fudan University in Shanghai, co-led by Dr. Yilai Shu, who trained in Chen’s lab, which collaborated on the research. Funders include Chinese science organizations and biotech company Shanghai Refreshgene Therapeutics.
Researchers observed the children for about six months. They don’t know why the treatment didn’t work in one of them. But the five others, who previously had complete deafness, can now hear a regular conversation and talk with others. Chen estimates they now hear at a level around 60% to 70% of normal. The therapy caused no major side effects.
Preliminary results from other research have been just as positive. New York’s Regeneron Pharmaceuticals announced in October that a child under 2 in a study they sponsored with Decibel Therapeutics showed improvements six weeks after gene therapy. The Philadelphia hospital — one of several sites in a test sponsored by a subsidiary of Eli Lilly called Akouos — reported that their patient, Aissam Dam of Spain, heard sounds for the first time after being treated in October. Though they are muffled like he’s wearing foam earplugs, he’s now able to hear his father’s voice and cars on the road, said Dr. John Germiller, who led the research in Philadelphia.
“It was a dramatic improvement,” Germiller said. “His hearing is improved from a state of complete and profound deafness with no sound at all to the level of mild to moderate hearing loss, which you can say is a mild disability. And that’s very exciting for us and for everyone. ”
Columbia University’s Dr. Lawrence Lustig, who is involved in the Regeneron trial, said although the children in these studies don’t wind up with perfect hearing, “even a moderate hearing loss recovery in these kids is pretty astounding.”
Still, he added, many questions remain, such as how long the therapies will last and whether hearing will continue to improve in the kids.
Also, some people consider gene therapy for deafness ethically problematic. Teresa Blankmeyer Burke, a deaf philosophy professor and bioethicist at Gallaudet University, said in an email that there’s no consensus about the need for gene therapy targeting deafness. She also pointed out that deafness doesn’t cause severe or deadly illness like, for example, sickle cell disease. She said it’s important to engage with deaf community members about prioritization of gene therapy, “particularly as this is perceived by many as potentially an existential threat to the flourishing of signing Deaf communities.”
Meanwhile, researchers said their work is moving forward.
“This is real proof showing gene therapy is working,” Chen said. “It opens up the whole field.”
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
veryGood! (35)
Related
- When is the 'Survivor' Season 47 finale? Here's who's left; how to watch and stream part one
- New U.S., Canada, Mexico Climate Alliance May Gain in Unity What It Lacks in Ambition
- Soon after Roe was overturned, one Mississippi woman learned she was pregnant
- Emissions of Nitrous Oxide, a Climate Super-Pollutant, Are Rising Fast on a Worst-Case Trajectory
- Lil Durk suspected of funding a 2022 murder as he seeks jail release in separate case
- American Climate Video: Giant Chunks of Ice Washed Across His Family’s Cattle Ranch
- Coach Outlet Memorial Day Sale 2023: Shop Trendy Handbags, Wallets & More Starting at $19
- Cyberattacks on hospitals 'should be considered a regional disaster,' researchers find
- Hate crime charges dropped against 12 college students arrested in Maryland assault
- Shift to Clean Energy Could Save Millions Who Die From Pollution
Ranking
- How to watch the 'Blue Bloods' Season 14 finale: Final episode premiere date, cast
- Premature Birth Rates Drop in California After Coal and Oil Plants Shut Down
- Cyberattacks on hospitals 'should be considered a regional disaster,' researchers find
- Sarah, the Duchess of York, undergoes surgery following breast cancer diagnosis
- Beyoncé will perform halftime during NFL Christmas Day Game: Here's what to know
- Inside Jeff Bezos' Mysterious Private World: A Dating Flow Chart, That Booming Laugh and Many Billions
- The world's worst industrial disaster harmed people even before they were born
- American Climate Video: On a Normal-Seeming Morning, the Fire Suddenly at Their Doorstep
Recommendation
-
Taylor Swift makes history as most decorated artist at Billboard Music Awards
-
Public Comments on Pipeline Plans May Be Slipping Through Cracks at FERC, Audit Says
-
Half the World’s Sandy Beaches May Disappear by Century’s End, Climate Study Says
-
A Judge’s Ruling Ousted Federal Lands Chief. Now Some Want His Decisions Tossed, Too
-
China's new tactic against Taiwan: drills 'that dare not speak their name'
-
He was diagnosed with ALS. Then they changed the face of medical advocacy
-
The Most Jaw-Dropping Deals at Anthropologie's Memorial Day Sale 2023: Save 40% on Dresses & More
-
Kim Kardashian Reveals the Meaningful Present She Gives Her 4 Kids Each Year on Their Birthdays
Tags
-
lotradecoin token
lotradecoin cryptocurrency news updates
lotradecoin integration with payment systems
lotradecoin withdrawal processing times
lotradecoin leaderboard
best strategies for lotradecoin trading
how to trade on lotradecoin
lotradecoin market analysis tools
lotradecoin blockchain network compatibility